Ann: Appendix 4D 31 December 2018, page-33

Thanks for clarifying a few accounting details Pman!

The half yearly is actually pretty good on reflection:
• royalties up
• add same R&D rebate as last year and we are cash flow positive
• Smart bottle formally acknowledged as OBJ tech
• Genoptics Pen ‘formally’ announced as OBJ integrated product

In addition “The Bodyguard team also developed a detailed business plan for the commercial roll-out of the Kneeguard product” - it’s happening. We are about to launch our own product leveraging the expertise of a team whom created a $250m cosmetics brand. 

Even better, there is plenty not included.